Results 141 to 150 of about 2,703,409 (308)

Data for: The Success of Sentinel Lymph Node Biopsy after Neoadjuvant Therapy: a Single Institution Review

open access: yes, 2017
Breast cancer database of neoadjuvant therapy patients from 2002 ...
Pockaj, B (via Mendeley Data)   +1 more
core   +1 more source

Long‐Term Stoma‐Free Outcomes After Diverting Stoma Closure Following Radiation‐Based Neoadjuvant Treatment for Rectal Cancer

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Aim Long‐term stoma‐free outcomes after diverting stoma closure in patients who underwent sphincter‐preserving rectal cancer surgery with double‐stapling technique (DST) reconstruction following radiation‐based neoadjuvant treatment remain unclear.
Hidetaka Ichikawa   +7 more
wiley   +1 more source

Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer

open access: yes, 2016
Breast cancer is a heterogeneous disease, and the different biological subtypes have different prognostic impacts. Neoadjuvant trials have recently become popular as they offer several advantages compared to traditional adjuvant trials.
Angela Pennisi   +4 more
core   +1 more source

Laparoscopic Surgery Is Associated With Reduced Small Bowel Obstruction Risk After Colorectal Cancer Surgery: A Nationwide Cohort Study of 5458 Patients

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Abbreviated Abstract This nationwide retrospective cohort study of 5458 colorectal cancer surgeries across 32 Japanese institutions examined the effects of laparoscopic surgery, adhesion prevention materials (APMs), and stoma creation on the 5‐year risk of small bowel obstruction (SBO).
Takeshi Yamada   +19 more
wiley   +1 more source

Effect of neoadjuvant therapy in patients with resected pancreatic adenocarcinoma.

open access: yes, 2014
338 Background: Retrospective data suggest that neoadjuvant therapy in patients with resectable pancreatic cancer may improve the R0 resection rate and potentially survival.
Noelle K. LoConte   +6 more
core   +1 more source

Can Chemoradiotherapy Expand Immune Checkpoint Blockade Responsiveness in Mismatch Repair‐Proficient Rectal Cancer?

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Immune checkpoint blockade (ICB) has transformed the treatment of mismatch repair‐deficient (dMMR) colorectal cancer but produces no meaningful benefit in advanced mismatch repair‐proficient (pMMR) disease. In the neoadjuvant setting, however, pathological responses have been reported in a subset of pMMR tumors, suggesting that clinical ...
Kimihiro Yamashita   +4 more
wiley   +1 more source

Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancer

open access: yes, 2019
Bing-Lei Ma,1,2,* Lin Yao,1,2,* Yu Fan,1,2 Yu Wang,1,2 Yi-Sen Meng,1,2 Qian Zhang,1,2 Zhi-Song He,1,2 Jie Jin,1,2 Li-Qun Zhou1,21Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s ...
Yao L   +8 more
core  

Minimally Invasive Versus Open Total and Distal Gastrectomy After Chemotherapy for Gastric Cancer: A Nationwide Observational Study

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This nationwide observational study used data from the National Clinical Database. Patients who underwent total or distal gastrectomy for gastric cancer after chemotherapy between January 2014 and December 2022 were included. Minimally invasive surgery was associated with lower incidences of overall postoperative complications of Clavien–Dindo grade ...
Nobuaki Hoshino   +8 more
wiley   +1 more source

Does loss of ARID1A expression affect neoadjuvant chemoradiotherapy response in rectal carcinomas?

open access: yesPolish Journal of Pathology
This study evaluated the difference of ARID1A protein immunoexpression between responders and non-responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancers.
Nagehan O. Barisik   +7 more
doaj   +1 more source

Neoadjuvant treatment in locally advanced rectal cancer

open access: yes, 2015
The optimal treatment for locally advanced rectal cancerremains an issue of debate. The surgery with total mesorectalexcision (TME) still is the standard of care.
KAYTAN SAGLAM, Esra, AKGUN, Zuleyha
core   +2 more sources

Home - About - Disclaimer - Privacy